Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
8204 | 1208 | 25.1 | 69% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
103 | 24571 | PARA TUBERCULOSIS//MYCOBACTERIUM BOVIS//JOHNES DISEASE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | RIFABUTIN | Author keyword | 19 | 30% | 4% | 54 |
2 | KRM 1648 | Author keyword | 18 | 89% | 1% | 8 |
3 | RIFALAZIL | Author keyword | 15 | 68% | 1% | 13 |
4 | BENZOXAZINORIFAMYCIN | Author keyword | 11 | 100% | 0% | 6 |
5 | MYCOBACTERIUM AVIUM COMPLEX | Author keyword | 8 | 15% | 4% | 50 |
6 | MYCOBACTERIUM AVIUM INTRACELLULARE | Author keyword | 6 | 26% | 2% | 19 |
7 | MYCOBACTERIUM AVIUM | Author keyword | 5 | 10% | 3% | 42 |
8 | ENDOBRONCHIAL GRANULOMA | Author keyword | 2 | 67% | 0% | 2 |
9 | DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX | Author keyword | 2 | 50% | 0% | 3 |
10 | DISSEMINATED MYCOBACTERIUM AVIUM | Author keyword | 1 | 100% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | INTRACELLULARE BACTEREMIA | 77 | 89% | 3% | 34 |
2 | ETHAMBUTOL | 34 | 23% | 11% | 131 |
3 | RIFABUTIN | 26 | 28% | 7% | 81 |
4 | CLOFAZIMINE | 22 | 32% | 5% | 58 |
5 | COMPLEX INFECTION | 19 | 28% | 5% | 58 |
6 | INTRACELLULARE | 17 | 17% | 8% | 92 |
7 | 2 CONTROLLED TRIALS | 16 | 64% | 1% | 16 |
8 | INTRACELLULARE INFECTIONS | 15 | 82% | 1% | 9 |
9 | INTRACELLULARE INFECTION | 14 | 44% | 2% | 25 |
10 | BEIGE MICE | 12 | 28% | 3% | 38 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
CURRENT CONCEPTS - MYCOBACTERIUM-AVIUM COMPLEX INFECTION IN THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME | 1991 | 692 | 50 | 56% |
Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy | 2004 | 80 | 64 | 63% |
Treatment outcomes for Mycobacterium avium complex: a systematic review and meta-analysis | 2014 | 8 | 37 | 57% |
Mycobacterium avium complex infection in HIV/AIDS patients | 2008 | 18 | 82 | 39% |
Fluoroquinolones: a new treatment for tuberculosis? | 1998 | 57 | 44 | 57% |
Primary Cutaneous Infection by Mycobacterium avium: A Case Report and Literature Review | 2012 | 4 | 17 | 53% |
Susceptibility testing of Mycobacterium avium complex isolates | 1996 | 65 | 85 | 61% |
Rifamycins - Obstacles and opportunities | 2010 | 32 | 188 | 25% |
The clinical use of fluoroquinolones for the treatment of mycobacterial diseases | 1997 | 86 | 45 | 29% |
RIFABUTIN - A REVIEW OF ITS ANTIMICROBIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC EFFICACY | 1994 | 85 | 85 | 71% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BACTERIOL HYG EPIDEMIOL HOSP | 1 | 50% | 0.1% | 1 |
2 | CAHRD | 1 | 50% | 0.1% | 1 |
3 | NELSON R MANDEL MED | 1 | 50% | 0.1% | 1 |
4 | SERV MALAD INFECT TROP NUTR CLIN | 1 | 50% | 0.1% | 1 |
5 | UNITE INSERM U 1088 | 1 | 50% | 0.1% | 1 |
6 | KUZELL ARTHRIT INFECT DIS | 0 | 11% | 0.3% | 4 |
7 | KUZELL ARTHRITIS INFECT DIS | 0 | 20% | 0.2% | 2 |
8 | TAKASAGO S | 0 | 13% | 0.2% | 3 |
9 | CENT BACTERIOL VIROL | 0 | 33% | 0.1% | 1 |
10 | INFECT DIS 151 | 0 | 33% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000208595 | NON TUBERCULOUS MYCOBACTERIA//MYCOBACTERIUM ABSCESSUS//RAPIDLY GROWING MYCOBACTERIA |
2 | 0.0000190619 | CAS 58001 44 8//HOSPITAL PATHOGENS//RV3676 |
3 | 0.0000175683 | KUZELL ARTHRIT INFECT DIS//MICROBIOL IMMUNOL INFECT//T CELL MITOGENESIS |
4 | 0.0000142984 | EARLY BACTERICIDAL ACTIVITY//DELAMANID//BEDAQUILINE |
5 | 0.0000138837 | GLYCOPEPTIDOLIPID//GLYCOPEPTIDOLIPIDS//PGPL MC |
6 | 0.0000124976 | CLOFAZIMINE//B669//RIMINOPHENAZINES |
7 | 0.0000122002 | NOVEL DRUG VACCINE DELIVERY SYST IL//INFECT DIS ANIM MODELS GRP//LIPOSOMAL ANTIBIOTIC |
8 | 0.0000105644 | ATOVAQUONE//TOXOPLASMIC ENCEPHALITIS//TOXOPLASMA ENCEPHALITIS |
9 | 0.0000090460 | MYCOBACTERIUM GENAVENSE//AVIAN MYCOBACTERIOSIS//MYCOBACTERIOSIS |
10 | 0.0000088844 | AURAMINE STAINING//ROMANOWSKY STAIN//NEGATIVE IMAGES |